{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:35Z","timestamp":1758585635484,"version":"3.44.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.pcl.2020.07.012","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T09:52:42Z","timestamp":1600854762000},"page":"1219-1235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hearing and Other Neurologic Problems"],"prefix":"10.1016","volume":"67","author":[{"given":"Wendy","family":"Landier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Cohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marry M.","family":"van den Heuvel-Eibrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.pcl.2020.07.012_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1044\/jshd.5101.53","article-title":"Effects of mild and moderate hearing impairments on language, educational, and psychosocial behavior of children","volume":"51","author":"Davis","year":"1986","journal-title":"J\u00a0Speech Hear Disord"},{"issue":"5","key":"10.1016\/j.pcl.2020.07.012_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00003446-199810000-00001","article-title":"Children with minimal sensorineural hearing loss: prevalence, educational performance, and functional status","volume":"19","author":"Bess","year":"1998","journal-title":"Ear Hear"},{"issue":"2","key":"10.1016\/j.pcl.2020.07.012_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00043426-199903000-00007","article-title":"Late effects of treatment for germ cell tumors during childhood and adolescence","volume":"21","author":"Hale","year":"1999","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.pcl.2020.07.012_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/cncr.22004","article-title":"Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma","volume":"107","author":"Kushner","year":"2006","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.pcl.2020.07.012_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/pbc.21875","article-title":"Ototoxicity in children treated for osteosarcoma","volume":"52","author":"Lewis","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.pcl.2020.07.012_bib6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/pbc.23275","article-title":"Hearing loss among survivors of childhood brain tumors treated with an irradiation-sparing approach","volume":"58","author":"Orgel","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.pcl.2020.07.012_bib7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/WNP.0b013e31823da494","article-title":"Neurophysiologic intraoperative monitoring of the vestibulocochlear nerve","volume":"28","author":"Simon","year":"2011","journal-title":"J\u00a0Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.pcl.2020.07.012_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3171\/2011.12.PEDS11357","article-title":"Cerebrospinal fluid shunting and hearing loss in patients treated for medulloblastoma","volume":"9","author":"Guillaume","year":"2012","journal-title":"J\u00a0Neurosurg Pediatr"},{"issue":"2","key":"10.1016\/j.pcl.2020.07.012_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.mph.0000199586.98926.8e","article-title":"Low incidence of ototoxicity with continuous infusion of cisplatin in the treatment of pediatric germ cell tumors","volume":"28","author":"Gupta","year":"2006","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.pcl.2020.07.012_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2013.51.2038","article-title":"Ototoxicity in children with high-risk neuroblastoma: prevalence, risk factors, and concordance of grading scales--a report from the Children's Oncology Group","volume":"32","author":"Landier","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"34","key":"10.1016\/j.pcl.2020.07.012_bib11","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1200\/JCO.2004.00.5355","article-title":"Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development","volume":"23","author":"Knight","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2020.07.012_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3892\/ol.2012.997","article-title":"Prospective evaluation of cisplatin- and carboplatin-mediated ototoxicity in paediatric and adult soft tissue and osteosarcoma patients","volume":"5","author":"Nitz","year":"2013","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.pcl.2020.07.012_bib13","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.1989.7.6.754","article-title":"Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation","volume":"7","author":"Schell","year":"1989","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.pcl.2020.07.012_bib14","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/MPH.0b013e31815d1d83","article-title":"Hearing loss in pediatric oncology patients receiving carboplatin-containing regimens","volume":"30","author":"Dean","year":"2008","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"2","key":"10.1016\/j.pcl.2020.07.012_bib15","doi-asserted-by":"crossref","first-page":"e0210646","DOI":"10.1371\/journal.pone.0210646","article-title":"A\u00a0comparison of the Muenster, SIOP Boston, Brock, Chang and CTCAEv4.03 ototoxicity grading scales applied to 3,799 audiograms of childhood cancer patients treated with platinum-based chemotherapy","volume":"14","author":"Clemens","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.pcl.2020.07.012_bib16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2016.09.023","article-title":"Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study","volume":"69","author":"Clemens","year":"2016","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.pcl.2020.07.012_bib17","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.ejca.2003.08.009","article-title":"Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose","volume":"40","author":"Li","year":"2004","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.pcl.2020.07.012_bib18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1081\/CNV-200055951","article-title":"Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance system","volume":"23","author":"Stohr","year":"2005","journal-title":"Cancer Invest"},{"issue":"19","key":"10.1016\/j.pcl.2020.07.012_bib19","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.2011.39.1110","article-title":"Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale","volume":"30","author":"Brock","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.pcl.2020.07.012_bib20","doi-asserted-by":"crossref","first-page":"dju044","DOI":"10.1093\/jnci\/dju044","article-title":"Chemotherapy-induced peripheral neurotoxicity and ototoxicity: new paradigms for translational genomics","volume":"106","author":"Travis","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.pcl.2020.07.012_bib21","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1158\/1055-9965.EPI-11-0659","article-title":"Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors","volume":"20","author":"Bhatia","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"10.1016\/j.pcl.2020.07.012_bib22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2217\/pgs.11.48","article-title":"Pharmacogenomics of cisplatin-induced ototoxicity","volume":"12","author":"Mukherjea","year":"2011","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.pcl.2020.07.012_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-3955(05)70077-8","article-title":"The case for early identification of hearing loss in children. Auditory system development, experimental auditory deprivation, and development of speech perception and hearing","volume":"46","author":"Sininger","year":"1999","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"10.1016\/j.pcl.2020.07.012_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1620\/tjem.219.177","article-title":"Cisplatin ototoxicity and protection: clinical and experimental studies","volume":"219","author":"Rybak","year":"2009","journal-title":"Tohoku J Exp Med"},{"issue":"8","key":"10.1016\/j.pcl.2020.07.012_bib25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.tips.2013.05.006","article-title":"Understanding platinum-induced ototoxicity","volume":"34","author":"Langer","year":"2013","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"10.1016\/j.pcl.2020.07.012_bib26","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/CAD.0b013e3283650bda","article-title":"Platinum compounds in children with cancer: toxicity and clinical management","volume":"24","author":"Ruggiero","year":"2013","journal-title":"Anticancer Drugs"},{"issue":"4","key":"10.1016\/j.pcl.2020.07.012_bib27","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1542\/peds.2009-1597","article-title":"Auditory late effects of childhood cancer therapy: a report from the Children's Oncology Group","volume":"125","author":"Grewal","year":"2010","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.pcl.2020.07.012_bib28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/pbc.20036","article-title":"Ototoxicity following pediatric hematopoietic stem cell transplantation: a prospective cohort study","volume":"42","author":"Punnett","year":"2004","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.pcl.2020.07.012_bib29","first-page":"676","article-title":"Ototoxicity associated with oxaliplatin in a patient with pancreatic cancer","volume":"14","author":"Oh","year":"2013","journal-title":"JOP"},{"issue":"8847","key":"10.1016\/j.pcl.2020.07.012_bib30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0140-6736(93)90523-J","article-title":"Ifosfamide and exacerbation of cisplatin-induced hearing loss","volume":"341","author":"Meyer","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.pcl.2020.07.012_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1358\/dot.2003.39.4.799404","article-title":"Aminoglycoside ototoxicity","volume":"39","author":"Bates","year":"2003","journal-title":"Drugs Today (Barc)"},{"issue":"5","key":"10.1016\/j.pcl.2020.07.012_bib32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0030-6665(20)30770-2","article-title":"Ototoxicity of loop diuretics","volume":"26","author":"Rybak","year":"1993","journal-title":"Otolaryngol Clin North Am"},{"issue":"11","key":"10.1016\/j.pcl.2020.07.012_bib33","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/ar.22578","article-title":"Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention","volume":"295","author":"Schacht","year":"2012","journal-title":"Anat Rec (Hoboken)"},{"issue":"11","key":"10.1016\/j.pcl.2020.07.012_bib34","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/ar.22577","article-title":"Review: ototoxic characteristics of platinum antitumor drugs","volume":"295","author":"Ding","year":"2012","journal-title":"Anat Rec (Hoboken)"},{"issue":"1","key":"10.1016\/j.pcl.2020.07.012_bib35","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat Commun"},{"issue":"1\u20132","key":"10.1016\/j.pcl.2020.07.012_bib36","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.heares.2011.01.011","article-title":"Development of tonotopy in the auditory periphery","volume":"276","author":"Mann","year":"2011","journal-title":"Hear Res"},{"key":"10.1016\/j.pcl.2020.07.012_bib37","series-title":"Otolaryngology head and neck surgery","first-page":"3186","article-title":"Vestibular and auditory ototoxicity","author":"Roland","year":"1998"},{"issue":"2","key":"10.1016\/j.pcl.2020.07.012_bib38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0022-3476(83)80551-4","article-title":"Hearing loss in children receiving cisplatin chemotherapy","volume":"102","author":"McHaney","year":"1983","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2020.07.012_bib39","series-title":"Otolaryngology","first-page":"1653","article-title":"Ototoxicity","author":"Stringer","year":"1991"},{"issue":"3","key":"10.1016\/j.pcl.2020.07.012_bib40","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2008.01.050","article-title":"Hearing loss after radiotherapy for pediatric brain tumors: effect of cochlear dose","volume":"72","author":"Hua","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.pcl.2020.07.012_bib41","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.ijrobp.2003.07.008","article-title":"Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors","volume":"58","author":"Merchant","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.pcl.2020.07.012_bib42","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/S1470-2045(18)30858-1","article-title":"Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium","volume":"20","author":"Clemens","year":"2019","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1016\/j.pcl.2020.07.012_bib43","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2015.63.6738","article-title":"Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer","volume":"34","author":"Bass","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2020.07.012_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/pbc.21530","article-title":"Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function","volume":"51","author":"Merchant","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.pcl.2020.07.012_bib45","series-title":"Management of head and neck cancer. A multidisciplinary approach","first-page":"173","article-title":"The effect of radiation on normal tissues of the head and neck","author":"Parsons","year":"1984"},{"issue":"11","key":"10.1016\/j.pcl.2020.07.012_bib46","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hed.23201","article-title":"Characteristics of radiation-induced sensorineural hearing loss in head and neck cancer: a systematic review","volume":"35","author":"Mujica-Mota","year":"2013","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.pcl.2020.07.012_bib47","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/000348940111001002","article-title":"Mechanism of hearing loss in irradiated ears: a long-term longitudinal study","volume":"110","author":"Young","year":"2001","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5","key":"10.1016\/j.pcl.2020.07.012_bib48","doi-asserted-by":"crossref","first-page":"e819","DOI":"10.1016\/j.ijrobp.2010.11.047","article-title":"Radiation-induced middle ear and mastoid opacification in skull base tumors treated with radiotherapy","volume":"81","author":"Walker","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.pcl.2020.07.012_bib49","first-page":"191","article-title":"Cisplatin and cranial irradiation-related hearing loss in children","volume":"12","author":"Warrier","year":"2012","journal-title":"Ochsner J"},{"issue":"108","key":"10.1016\/j.pcl.2020.07.012_bib50","first-page":"57","article-title":"Cisplatin based chemoradiation late toxicities in head and neck squamous cell carcinoma patients","volume":"20","author":"Rivelli","year":"2015","journal-title":"Discov Med"},{"issue":"3","key":"10.1016\/j.pcl.2020.07.012_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/coa.12527","article-title":"Hearing loss in survivors of childhood head and neck rhabdomyosarcoma; a long-term follow-up study","volume":"41","author":"Schoot","year":"2016","journal-title":"Clin Otolaryngol"},{"issue":"1","key":"10.1016\/j.pcl.2020.07.012_bib52","first-page":"131","article-title":"Durability of hearing preservation after microsurgical treatment of vestibular schwannoma using the middle cranial fossa approach","volume":"119","author":"Wang","year":"2013","journal-title":"J\u00a0Neurosurg"},{"issue":"5","key":"10.1016\/j.pcl.2020.07.012_bib53","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archotol.130.5.556","article-title":"The importance of high-frequency audibility in the speech and language development of children with hearing loss","volume":"130","author":"Stelmachowicz","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"5","key":"10.1016\/j.pcl.2020.07.012_bib54","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2007-0178","article-title":"Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group","volume":"120","author":"Gurney","year":"2007","journal-title":"Pediatrics"},{"issue":"sup4","key":"10.1016\/j.pcl.2020.07.012_bib55","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1080\/14992027.2017.1355570","article-title":"Ototoxicity monitoring in children treated with platinum chemotherapy","volume":"57","author":"Brooks","year":"2018","journal-title":"Int J Audiol"},{"year":"1998","series-title":"Clinical audiology: an introduction","author":"Stach","key":"10.1016\/j.pcl.2020.07.012_bib56"},{"issue":"4","key":"10.1016\/j.pcl.2020.07.012_bib57","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mpo.2950190415","article-title":"Cisplatin ototoxicity in children: a practical grading system","volume":"19","author":"Brock","year":"1991","journal-title":"Med Pediatr Oncol"},{"issue":"4","key":"10.1016\/j.pcl.2020.07.012_bib58","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejca.2005.11.004","article-title":"Assessment of hearing in very young children receiving carboplatin for retinoblastoma","volume":"42","author":"Smits","year":"2006","journal-title":"Eur J Cancer"},{"issue":"10","key":"10.1016\/j.pcl.2020.07.012_bib59","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1200\/JCO.2006.07.9723","article-title":"Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions","volume":"25","author":"Knight","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"year":"2013","series-title":"Children's Oncology Group long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers, version 4.0","key":"10.1016\/j.pcl.2020.07.012_bib60"},{"year":"2010","series-title":"Guidelines for follow-up in survivors of childhood cancer 5 years after diagnosis","key":"10.1016\/j.pcl.2020.07.012_bib61"},{"year":"2011","series-title":"Therapy based long-term follow-up practice statement","key":"10.1016\/j.pcl.2020.07.012_bib62"},{"issue":"10","key":"10.1016\/j.pcl.2020.07.012_bib63","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.2009.26.7872","article-title":"Critical need for international consensus on ototoxicity assessment criteria","volume":"28","author":"Neuwelt","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.pcl.2020.07.012_bib64","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0031-3955(05)70086-9","article-title":"Management of the child with sensorineural hearing loss. Medical, surgical, hearing aids, cochlear implants","volume":"46","author":"Brookhouser","year":"1999","journal-title":"Pediatr Clin North Am"},{"issue":"11","key":"10.1016\/j.pcl.2020.07.012_bib65","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/cncr.29779","article-title":"Ototoxicity and cancer therapy","volume":"122","author":"Landier","year":"2016","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.pcl.2020.07.012_bib66","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2352-4642(19)30115-4","article-title":"Interventions for cisplatin-induced hearing loss in children and adolescents with cancer","volume":"3","author":"Freyer","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"issue":"9","key":"10.1016\/j.pcl.2020.07.012_bib67","article-title":"Medical interventions for the prevention of platinum-induced hearing loss in children with cancer","author":"van As","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1\u20132","key":"10.1016\/j.pcl.2020.07.012_bib68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.heares.2006.09.015","article-title":"Mechanisms of cisplatin-induced ototoxicity and prevention","volume":"226","author":"Rybak","year":"2007","journal-title":"Hear Res"},{"issue":"24","key":"10.1016\/j.pcl.2020.07.012_bib69","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1002\/cncr.24667","article-title":"Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma: a report of the Intergroup Hepatoblastoma Study P9645 as a part of the Children's Oncology Group","volume":"115","author":"Katzenstein","year":"2009","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.pcl.2020.07.012_bib70","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/cncr.21218","article-title":"Amifostine does not protect against the ototoxicity of high-dose cisplatin combined with etoposide and bleomycin in pediatric germ-cell tumors: a Children's Oncology Group study","volume":"104","author":"Marina","year":"2005","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.pcl.2020.07.012_bib71","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/neuonc\/not241","article-title":"Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma","volume":"16","author":"Gurney","year":"2014","journal-title":"Neuro Oncol"},{"issue":"25","key":"10.1016\/j.pcl.2020.07.012_bib72","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium thiosulfate for protection from cisplatin-induced hearing loss","volume":"378","author":"Brock","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.pcl.2020.07.012_bib73","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1470-2045(16)30625-8","article-title":"Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial","volume":"18","author":"Freyer","year":"2017","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.pcl.2020.07.012_bib74","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.1990.8.12.2091","article-title":"Potentiation of cisplatin ototoxicity by noise","volume":"8","author":"Gratton","year":"1990","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.pcl.2020.07.012_bib75","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1038\/ng.478","article-title":"Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy","volume":"41","author":"Ross","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.pcl.2020.07.012_bib76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.critrevonc.2018.04.001","article-title":"The influence of genetic variation on late toxicities in childhood cancer survivors: A review","volume":"126","author":"Clemens","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.pcl.2020.07.012_bib77","doi-asserted-by":"crossref","first-page":"e11868","DOI":"10.2196\/11868","article-title":"Genetic determinants of ototoxicity during and after childhood cancer treatment: protocol for the PanCareLIFE Study","volume":"8","author":"Clemens","year":"2019","journal-title":"JMIR Res Protoc"},{"issue":"3","key":"10.1016\/j.pcl.2020.07.012_bib78","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng.3217","article-title":"Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss","volume":"47","author":"Xu","year":"2015","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.pcl.2020.07.012_bib79","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/tpj.2009.19","article-title":"Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients","volume":"9","author":"Caronia","year":"2009","journal-title":"Pharmacogenomics J"},{"issue":"4","key":"10.1016\/j.pcl.2020.07.012_bib80","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/pbc.24366","article-title":"Glutathione S-transferase P1 single nucleotide polymorphism predicts permanent ototoxicity in children with medulloblastoma","volume":"60","author":"Rednam","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.pcl.2020.07.012_bib81","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.bbrc.2006.05.208","article-title":"Mitochondrial 12S rRNA A827G mutation is involved in the genetic susceptibility to aminoglycoside ototoxicity","volume":"346","author":"Xing","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pcl.2020.07.012_bib82","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.heares.2012.05.009","article-title":"An active loudness model suggesting tinnitus as increased central noise and hyperacusis as increased nonlinear gain","volume":"295","author":"Zeng","year":"2013","journal-title":"Hear Res"},{"key":"10.1016\/j.pcl.2020.07.012_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2019.01.004","article-title":"Tinnitus during and after childhood cancer: A systematic review","volume":"135","author":"Meijer","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"10.1016\/j.pcl.2020.07.012_bib84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/neuonc\/nox148","article-title":"Longitudinal assessment of late-onset neurologic conditions in survivors of childhood central nervous system tumors: a Childhood Cancer Survivor Study report","volume":"20","author":"Wells","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.pcl.2020.07.012_bib85","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ctrv.2016.09.005","article-title":"Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge","volume":"50","author":"Kandula","year":"2016","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"10.1016\/j.pcl.2020.07.012_bib86","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jamaneurol.2018.0963","article-title":"Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer: clinical, neurophysiological, functional, and patient-reported outcomes","volume":"75","author":"Kandula","year":"2018","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.pcl.2020.07.012_bib87","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.apmr.2013.03.009","article-title":"Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study","volume":"94","author":"Ness","year":"2013","journal-title":"Arch Phys Med Rehabil"},{"issue":"10","key":"10.1016\/j.pcl.2020.07.012_bib88","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1200\/JCO.2009.24.4228","article-title":"Practical grading system for evaluating cisplatin ototoxicity in children","volume":"28","author":"Chang","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.pcl.2020.07.012_bib89","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00106-005-1368-1","article-title":"[The \"Muenster classification\" of high frequency hearing loss following cisplatin chemotherapy]","volume":"55","author":"Schmidt","year":"2007","journal-title":"HNO"},{"year":"2010","series-title":"Common terminology criteria for adverse events, version 4.03","key":"10.1016\/j.pcl.2020.07.012_bib90"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003139552030105X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003139552030105X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:24:58Z","timestamp":1758475498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003139552030105X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":90,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S003139552030105X"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2020.07.012","relation":{},"ISSN":["0031-3955"],"issn-type":[{"type":"print","value":"0031-3955"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hearing and Other Neurologic Problems","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2020.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}